Well maybe but maybe there are other outcomes.
Might get FDA and successful percutaneous trial and flofirinox trial and be bought for 10 cents.
Or they might raise after those 3 outcomes again next year at 0.9 as foreshadowed with the sp at 5 cents.
It’s all risk on atm thus the price. I get that.
But the board has been cleared of the characters who were a bad influence and the settings are right.
Lots of shares on issue though. I get that.
I think it’s worth the punt.
Let’s see who agrees when the list of holders comes out
Ann: Two more PANCOSIL Trial treatments using OncoSil device, page-41
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(4.00%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $128.9K | 9.922M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 3433006 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 407094 | 5 |
View Market Depth
| Last trade - 11.44am 13/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |